Viatris, Inc. (VTRS)
18.66
+0.44
(+2.39%)
USD |
NASDAQ |
Oct 16, 16:00
18.64
-0.02
(-0.08%)
After-Hours: 20:00
Viatris Free Cash Flow (Quarterly) : 328.00M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 328.00M |
| March 31, 2026 | 266.40M |
| December 31, 2025 | 565.90M |
| September 30, 2025 | 645.20M |
| June 30, 2025 | 165.60M |
| March 31, 2025 | 474.10M |
| December 31, 2024 | 329.30M |
| September 30, 2024 | 741.10M |
| June 30, 2024 | 309.60M |
| March 31, 2024 | 563.80M |
| December 31, 2023 | 278.50M |
| September 30, 2023 | 732.00M |
| June 30, 2023 | 425.90M |
| March 31, 2023 | 888.70M |
| December 31, 2022 | -23.30M |
| September 30, 2022 | 753.30M |
| June 30, 2022 | 713.00M |
| March 31, 2022 | 1.067B |
| December 31, 2021 | 301.70M |
| September 30, 2021 | 953.70M |
| June 30, 2021 | 456.50M |
| March 31, 2021 | 795.60M |
| December 31, 2020 | -518.90M |
| September 30, 2020 | 486.80M |
| June 30, 2020 | 335.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 247.70M |
| December 31, 2019 | 420.30M |
| September 30, 2019 | 445.40M |
| June 30, 2019 | 624.80M |
| March 31, 2019 | -92.80M |
| December 31, 2018 | 521.40M |
| September 30, 2018 | 592.10M |
| June 30, 2018 | 385.00M |
| March 31, 2018 | 591.10M |
| December 31, 2017 | 314.50M |
| September 30, 2017 | 421.70M |
| June 30, 2017 | 41.60M |
| March 31, 2017 | 390.80M |
| December 31, 2016 | 34.70M |
| September 30, 2016 | 1.066B |
| June 30, 2016 | 273.00M |
| March 31, 2016 | -76.90M |
| December 31, 2015 | 392.20M |
| September 30, 2015 | 600.70M |
| June 30, 2015 | -63.50M |
| March 31, 2015 | 207.40M |
| December 31, 2014 | -29.70M |
| September 30, 2014 | 131.20M |
| June 30, 2014 | 92.10M |
| March 31, 2014 | 66.80M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Pacira Biosciences, Inc. | 56.12M |
| Eli Lilly & Co. | 4.475B |
| Pfizer Inc. | 302.00M |
| Merck & Co., Inc. | 4.477B |
| Bristol Myers Squibb Co. | 3.088B |